BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10800445)

  • 1. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
    Frietsch T; Lenz C; Waschke KF
    Dtsch Med Wochenschr; 2000 Apr; 125(15):465-72. PubMed ID: 10800445
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Artificial oxygen carriers--perfluorocarbons].
    Grünert A
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():57-62. PubMed ID: 7841781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human infusion of perfluorocarbons as blood substitutes].
    Ivanov KP
    Gematol Transfuziol; 1984 Jul; 29(7):40-7. PubMed ID: 6381221
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous perfluorocarbons: 30 years of research--what now?].
    Max M; Roissant R
    Dtsch Med Wochenschr; 2000 Apr; 125(15):444. PubMed ID: 10800440
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood Substitutes and Oxygen Therapeutics: A Review.
    Jahr JS; Guinn NR; Lowery DR; Shore-Lesserson L; Shander A
    Anesth Analg; 2021 Jan; 132(1):119-129. PubMed ID: 30925560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical oxygen transport using perfluorochemicals.
    Kaufman RJ
    Biotechnology; 1991; 19():127-62. PubMed ID: 1786469
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure-property correlation: estimates of the half-clearance time of perfluororganic compounds.
    Golovanov IB; Ivanitskii GR; Tsygankova IG; Khabarova MI
    Dokl Biochem; 2000; 371(1-6):63-8. PubMed ID: 10853453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of acute exudative inflammation in rats upon perftoran infusion].
    Lykova OF; Romanova TV; Moiseeva LM; Konysheva TV; Zorin NA
    Eksp Klin Farmakol; 2007; 70(1):60-2. PubMed ID: 17402596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorochemical-based artificial oxygen carrying red cell substitutes.
    Lane TA
    Transfus Sci; 1995 Mar; 16(1):19-31. PubMed ID: 10155703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial oxygen carriers--the new doping threat in endurance sport?
    Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H
    Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of emulsion concentration on biodistribution of perflubron in tumor-bearing mice.
    Long DM; Witt BL; Escobar JA; Long RA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):907-10. PubMed ID: 1391531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.
    Flaim SF
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1043-54. PubMed ID: 7849908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and mechanism of side-effects of Imagent BP (highly concentrated fluorocarbon emulsion) in swine.
    Flaim SF; Hazard DR; Hogan J; Peters RM
    Invest Radiol; 1991 Nov; 26 Suppl 1():S122-4; discussion S125-8. PubMed ID: 1808107
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous artificial oxygen carriers.
    Farrar D; Grocott M
    Hosp Med; 2003 Jun; 64(6):352-6. PubMed ID: 12833830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gas exchange and blood circulation status in dogs following replacement of acute blood loss by perfluoro compound emulsions].
    Akhsianov UU; Afonin NI; Troitskiĭ VB; Sukiasian GV; Karpov AP
    Biull Eksp Biol Med; 1983 Sep; 96(9):21-3. PubMed ID: 6616046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel fluorocarbon-based injectable oxygen-carrying formulations with long-term room-temperature storage stability.
    Riess JG; Cornelus C; Follana R; Krafft MP; Mahé AM; Postel M; Zarif L
    Adv Exp Med Biol; 1994; 345():227-34. PubMed ID: 8079712
    [No Abstract]   [Full Text] [Related]  

  • 20. Stability and stabilization of fluorocarbon emulsions destined for injection.
    Riess JG; Postel M
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):819-30. PubMed ID: 1391516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.